| Host: |
Rabbit |
| Applications: |
IF/ELISA |
| Reactivity: |
Human/Rat/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Proteinase-activated receptor 3 (38-87 aa) is suitable for use in Immunofluorescence and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
IF 1:200-1:1000ELISA 1:10000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
F2RL2 |
| Gene ID: |
2151 |
| Uniprot ID: |
PAR3_HUMAN |
| Immunogen Region: |
38-87 aa |
| Specificity: |
PAR-3 Polyclonal Antibody detects endogenous levels of PAR-3 protein. |
| Immunogen: |
The antiserum was produced against synthesized peptide derived from the human F2RL2 at the amino acid range 38-87 |
| Post Translational Modifications | A proteolytic cleavage generates a new N-terminus that functions as a tethered ligand. |
| Function | Receptor for activated thrombin coupled to G proteins that stimulate phosphoinositide hydrolysis. |
| Protein Name | Proteinase-Activated Receptor 3Par-3Coagulation Factor Ii Receptor-Like 2Thrombin Receptor-Like 2 |
| Database Links | Reactome: R-HSA-375276Reactome: R-HSA-416476Reactome: R-HSA-456926 |
| Cellular Localisation | Cell MembraneMulti-Pass Membrane Protein |
| Alternative Antibody Names | Anti-Proteinase-Activated Receptor 3 antibodyAnti-Par-3 antibodyAnti-Coagulation Factor Ii Receptor-Like 2 antibodyAnti-Thrombin Receptor-Like 2 antibodyAnti-F2RL2 antibodyAnti-PAR3 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
